In samples obtained from patients with stage 4 disease obtained after chemotherapy treatment, 5 of 6 patients demonstrated increased UBE4B expression (83%; p = 0.0019), suggesting that an increase in UBE4B expression occurs in response to chemotherapy treatment in patients with stage 4 neuroblastoma. Here, UBE4B is linked to neuroblastoma.